関連する実験動画
Updated: Feb 20, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.9K
肥満の流行は米国人の間で流行しています. 障がいのある人や無障害の成人を対象としています
Cheryl D Fryar1, Julie D Weeks2, Catharine A Couch1
1Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA.
Obesity (Silver Spring, Md.)
|February 18, 2026
まとめ
障害のある成人は,さまざまな要因を考慮した後でも,無障害者よりも肥満の罹患率が高くなります. これは,障害者集団に対する重大な公衆衛生上の懸念を強調しています.
科学分野:
- 公衆衛生は公衆衛生である.
- エピデミオロジー エピデミオロジー
- 障害に関する研究 障害に関する研究
背景:
- 肥満は,健康に重大な影響を及ぼす主要な公衆衛生問題です.
- 障害者を含むさまざまな人口サブグループにおける肥満の流行を理解することは,標的を絞った介入に不可欠です.
研究 の 目的:
- 障害者および無障害の米国成人の肥満の流行に関する現在の,全国的に代表的な推定値を提供するためです.
- 成人人口における肥満と障害状態の関連性を調べる.
主な方法:
- 国立健康栄養検査調査 (2021年8月~2023年8月) の5917人の成人 (20歳以上) のデータを活用した.
- 体重指数 (BMI) ≥30.0で測定した肥満を定義する. 自己報告された機能的困難に基づく定義された障害.
- 肥満と障害の関連性を評価するために,社会統計学的,行動的,および健康状態の変数を調整したロジスティック回帰モデルを使用しました.
主要な成果:
- 全体として,成人の40.3%が肥満で,16.5%が障害を報告しました.
- 障害のある成人は,障害のない人 (37.9%) と比較して,年齢調整された肥満の罹患率 (50.6%) を高めた.
- 複数の要因を考慮した結果でも,障害のある成人の肥満の割合は著しく高かった (調整された罹患率=1.14).
結論:
- 障害のある成人の肥満率の上昇は,年齢,性別,人種,ヒスパニック出身,教育,喫煙,健康状態の違いによって説明できない.
- 発見は,肥満率の持続的な格差を強調し,障害のある個人に合わせた公衆衛生戦略の必要性を強調しています.
関連する概念動画
Drug Dosing: Obese Patients
279
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
208
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208
Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Prevalence and Incidence
2.0K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.0K

